Amir Mohammad Kazemifar
Department of Toxicology, Qazvin University of Medical Sciences, Qazvin, Iran
[ 1 ] - Silymarin in treatment of non-alcoholic steatohepatitis: A randomized clinical trial
Abstract Background: No pharmacologic agents have been approved for the treatment of non-alcoholic steatohepatitis (NASH) that is common in our region. The present study was designed to evaluate the efficacy of silymarin, a known herbal drug, in the treatment of NASH. Methods: This clinical-trial study was conducted on 64 patients with NASH who were randomly divided as case group (33) and con...
Co-Authors